On this episode of Investor Connect, Hall welcomes Dr. Ipshita Mandal-Johnson, Co-founder and CEO, and Giorgio Reggiani, Co-founder and CFO at Global Bio Fund.
GBF is a value-capital fund with a gender smart lens investing in bio sectors, including digital health. They invest and scale women-led bio ventures at early and growth stages, especially those based in the US, UK, Australasia, and selected high-growth emerging markets.
GBF has also created GBX, a network that consists of a diverse and experienced group of investors, entrepreneurs, scientists, experts, and organizations that support women-led bio ventures that are growth and impact-oriented.
Ipshita currently serves on the advisory boards of Proximie, Chiasma NZ, and Global Engineering Futures. She is a Judge on Mass Challenge and Women in Bio and a member of Global Women and UNAIDS HIEx Investors Council. She is a Visiting Lecturer at the Harvard School of Public Health and the University of Cambridge Chemical Engineering & Biotech.
Ipshita has worked with academia, corporates, and ministries in biotechnology, health, deep technology, and financial services. She has led strategy, policy, and implementation projects in policy development, capacity building, business development, fundraising, and transformation. She started her career in New Zealand and has since worked in the US, UK, and India, amongst others.
For her full bio, click here.
Giorgio is passionate about working with teams that want to make a difference by helping them to create and realise optimum value. Co-founder of a leading European venture capitalist firm, a software configuration company, an antibiotics discovery company (sold to Summit in 2017), and a rare diseases therapies biotech (sold to Astellas Pharma) in 2020 and spun companies out of British Telecom & Toshiba and managed listed companies in London and Sydney.
For his full bio, click here.
Visit Global Bio Fund at www.globalbiofund.org, on LinkedIn at www.linkedin.com/company/global-bio-fund/, and on Twitter at www.twitter.com/GlobalBioFund.
Reach out to Ipshita at firstname.lastname@example.org, and on LinkedIn at www.linkedin.com/in/ipshitamj/.
For a full transcript, click here.
For more episodes from Investor Connect, please visit the site at: http://investorconnect.org
Check out our other podcasts here: https://investorconnect.org/
For Investors check out: https://tencapital.group/investor-landing/
For Startups check out: https://tencapital.group/company-landing/
For eGuides check out: https://tencapital.group/education/
For upcoming Events, check out https://tencapital.group/events/
For Feedback please contact email@example.com
Please follow, share, and leave a review.
Music courtesy of Bensound.
Copyright (c) 2022, Hall Martin and investorconnect.org. All rights reserved.
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.